Clinical-stage biopharmaceutical company atai Life Sciences ATAI announced the dosing of the first subject in phase 1 of its intravenous to subcutaneous phase 1 subsidiary
Clinical-stage psychedelics biotech at Life Sciences ATAI announced the results of its New York-based Perception Neuroscience subsidiary’s Phase 2a study of its proprietary R-ketamine PCN-101
US stocks were mostly higher at the end of trading, with the Dow Jones up around 150 points on Friday. The Dow rose 0.45% to
Cathie Wood’s ARK Genomic Revolution EFT has made big investments in the psychedelics sector since February 2022, specifically in Atai Life Sciences ATAI. The fund
– A non-dilutive financing facility plus $312 million of existing cash as of June 30, 2022 gives atai access to up to $487 million to
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within
injuredly News Provide the latest news. All News World News, Business News, Health Care, Life Style. All News Around the World Update On This Website.